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PURPOSE: Inherited retinal dystrophies (IRDs) and inherited optic neuropathies
(IONs) are rare diseases defined by specific clinical and molecular features. The
relative prevalence of these conditions was determined in Southern France.
METHODS: Patients recruited from a specialized outpatient clinic over a 21-year
period underwent extensive clinical investigations and 107 genes were screened by
polymerase chain reaction/sequencing.
RESULTS: There were 1957 IRD cases (1481 families) distributed in 70% of
pigmentary retinopathy cases (56% non-syndromic, 14% syndromic), 20%
maculopathies and 7% stationary conditions. Patients with retinitis pigmentosa were
the most frequent (47%) followed by Usher syndrome (10.8%). Among non-syndromic
pigmentary retinopathy patients, 84% had rod-cone dystrophy, 8% cone-rod
dystrophy and 5% Leber congenital amaurosis. Macular dystrophies were
encountered in 398 cases (30% had Stargardt disease and 11% had Best disease).
There were 184 ION cases (127 families) distributed in 51% with dominant optic
neuropathies, 33% with recessive/sporadic forms and 16% with Leber hereditary
optic neuropathy. Positive molecular results were obtained in 417/609 families with
IRDs (68.5%) and in 27/58 with IONs (46.5%). The sequencing of 5 genes (ABCA4,
USH2A, MYO7A, RPGR and PRPH2) provided a positive molecular result in 48% of
417 families with IRDs. Except for autosomal retinitis pigmentosa, in which less than
half the families had positive molecular results, about 75% of families with other
forms of retinal conditions had a positive molecular diagnosis.
CONCLUSIONS: Although gene discovery considerably improved molecular
diagnosis in many subgroups of IRDs and IONs, retinitis pigmentosa, accounting for
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